OmniAb (OABI) Financials

$1.62 -0.21 (-11.26%)

Closing price 04:00 PM Eastern

Extended Trading

$1.63 +0.01 (+0.93%)

As of 04:20 PM Eastern

Annual Income Statements for OmniAb

This table shows OmniAb's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-27	-22	-51	-62
Consolidated Net Income / (Loss)	-27	-22	-51	-62
Net Income / (Loss) Continuing Operations	-27	-22	-51	-62
Total Pre-Tax Income	-34	-26	-64	-71
Total Operating Income	-36	-27	-69	-75
Total Gross Profit	35	59	34	26
Total Revenue	35	59	34	26
Operating Revenue	35	59	34	26
Total Cost of Revenue	0.00	0.00	0.00	0.00
Total Operating Expenses	70	86	104	101
Selling, General & Admin Expense	17	25	33	31
Research & Development Expense	39	48	57	55
Amortization Expense	13	13	14	17
Other Operating Expenses / (Income)	1.21	-0.59	0.19	-2.37
Total Other Income / (Expense), net	1.26	0.59	5.06	3.09
Interest & Investment Income	0.00	0.59	5.06	3.11
Other Income / (Expense), net	1.27	0.00	0.00	-0.02
Income Tax Expense	-7.31	-3.73	-14	-9.38
Basic Earnings per Share	($0.33)	($0.26)	($0.51)	($0.61)
Weighted Average Basic Shares Outstanding	82.61M	85.32M	99.68M	102.37M
Diluted Earnings per Share	($0.33)	($0.26)	($0.51)	($0.61)
Weighted Average Diluted Shares Outstanding	82.61M	85.32M	99.68M	102.37M
Weighted Average Basic & Diluted Shares Outstanding	-	115.58M	117.13M	122.13M

This table shows OmniAb's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-13	6.82	-6.10	-15	-16	-14	-19	-14	-16	-13
Consolidated Net Income / (Loss)	-13	6.82	-6.10	-15	-16	-14	-19	-14	-16	-13
Net Income / (Loss) Continuing Operations	-13	6.82	-6.10	-15	-16	-14	-19	-14	-16	-13
Total Pre-Tax Income	-15	9.64	-7.13	-18	-19	-20	-22	-16	-19	-15
Total Operating Income	-15	9.05	-8.45	-19	-20	-21	-23	-16	-20	-16
Total Gross Profit	6.91	35	17	6.95	5.48	4.82	3.80	7.61	4.17	11
Total Revenue	6.91	35	17	6.95	5.48	4.82	3.80	7.61	4.17	11
Operating Revenue	6.91	35	17	6.95	5.48	4.82	3.80	7.61	4.17	11
Total Operating Expenses	22	26	25	26	26	26	26	24	24	27
Selling, General & Admin Expense	5.58	10	8.20	8.74	8.51	7.87	8.34	7.97	7.08	7.36
Research & Development Expense	13	13	14	14	14	15	15	14	13	13
Amortization Expense	3.26	3.28	3.37	3.38	3.40	3.41	3.41	4.54	3.39	6.06
Other Operating Expenses / (Income)	-0.21	-0.11	0.05	0.14	0.02	-0.01	0.05	-2.52	0.15	-0.04
Total Other Income / (Expense), net	0.00	0.59	1.32	1.28	1.27	1.18	0.98	0.78	0.68	0.66
Interest & Investment Income	0.00	0.59	1.32	1.29	1.27	1.18	0.98	0.79	0.69	0.66
Income Tax Expense	-2.31	2.82	-1.03	-3.44	-3.30	-5.98	-2.62	-1.90	-2.71	-2.16
Basic Earnings per Share	($0.15)	$0.09	($0.06)	($0.15)	($0.16)	($0.14)	($0.19)	($0.13)	($0.16)	($0.13)
Weighted Average Basic Shares Outstanding	82.61M	85.32M	99.16M	99.49M	99.91M	99.68M	100.76M	101.46M	102.39M	102.37M
Diluted Earnings per Share	($0.15)	$0.09	($0.06)	($0.15)	($0.16)	($0.14)	($0.19)	($0.13)	($0.16)	($0.13)
Weighted Average Diluted Shares Outstanding	82.61M	85.32M	99.16M	99.49M	99.91M	99.68M	100.76M	101.46M	102.39M	102.37M
Weighted Average Basic & Diluted Shares Outstanding	0.00	115.58M	115.60M	116.17M	116.24M	117.13M	117.62M	118.16M	121.01M	122.13M

This table details how cash moves in and out of OmniAb's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	0.00	34	-17	11
Net Cash From Operating Activities	-5.67	-3.59	2.35	-40
Net Cash From Continuing Operating Activities	-5.67	-3.59	2.35	-40
Net Income / (Loss) Continuing Operations	-27	-22	-51	-62
Consolidated Net Income / (Loss)	-27	-22	-51	-62
Depreciation Expense	16	18	19	24
Amortization Expense	-	-0.17	-3.44	-1.50
Non-Cash Adjustments To Reconcile Net Income	14	19	25	22
Changes in Operating Assets and Liabilities, net	-8.75	-18	12	-22
Net Cash From Investing Activities	-4.03	-73	-18	38
Net Cash From Continuing Investing Activities	-4.03	-73	-18	38
Purchase of Property, Plant & Equipment	-4.07	-17	-1.64	-1.88
Purchase of Investments	0.00	-55	-113	-40
Sale and/or Maturity of Investments	1.27	0.07	100	80
Other Investing Activities, net	-1.22	-1.44	-4.44	-0.40
Net Cash From Financing Activities	9.70	111	-0.89	13
Net Cash From Continuing Financing Activities	9.70	111	-0.89	13
Issuance of Common Equity	0.00	97	1.21	15
Other Financing Activities, net	9.70	14	-2.10	-1.61
Cash Income Taxes Paid	-	0.00	2.61	0.02

This table details how cash moves in and out of OmniAb's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	-	34	-11	-1.76	0.26	-4.89	2.70	1.73	6.44	0.36
Net Cash From Operating Activities	-4.23	-7.14	28	-10	-6.20	-9.12	-17	-12	-6.58	-3.87
Net Cash From Continuing Operating Activities	-4.23	-7.14	28	-10	-6.20	-9.12	-17	-12	-6.58	-3.87
Net Income / (Loss) Continuing Operations	-13	6.82	-6.10	-15	-16	-14	-19	-14	-16	-13
Consolidated Net Income / (Loss)	-13	6.82	-6.10	-15	-16	-14	-19	-14	-16	-13
Depreciation Expense	4.50	4.82	4.86	4.86	4.84	4.93	4.95	6.10	4.93	7.61
Amortization Expense	-	-0.17	-0.93	-0.89	-0.83	-0.79	-0.62	-0.38	-0.29	-0.21
Non-Cash Adjustments To Reconcile Net Income	5.11	6.37	6.03	7.09	5.86	5.94	5.68	5.93	5.30	5.14
Changes in Operating Assets and Liabilities, net	-1.25	-25	24	-6.36	-0.34	-5.15	-8.08	-10	-0.14	-3.33
Net Cash From Investing Activities	-4.88	-60	-37	7.78	6.29	4.73	20	13	4.45	0.39
Net Cash From Continuing Investing Activities	-4.88	-60	-37	7.78	6.29	4.73	20	13	4.45	0.39
Purchase of Property, Plant & Equipment	-3.92	-5.02	-0.23	-0.81	-0.49	-0.11	-0.93	-0.75	-0.15	-0.05
Purchase of Investments	-	-55	-39	-17	-31	-26	-5.42	-11	-8.98	-15
Sale and/or Maturity of Investments	-	0.07	4.21	26	38	31	27	25	14	15
Net Cash From Financing Activities	9.11	101	-1.05	0.48	0.17	-0.50	-0.20	0.80	8.57	3.85
Net Cash From Continuing Financing Activities	9.11	101	-1.05	0.48	0.17	-0.50	-0.20	0.80	8.57	3.85
Issuance of Common Equity	-	97	0.19	0.62	0.19	0.22	1.00	1.14	8.59	3.90
Other Financing Activities, net	9.11	4.32	-1.23	-0.14	-0.02	-0.71	-1.21	-0.34	-0.02	-0.05

This table presents OmniAb's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	304	421	375	326
Total Current Assets	23	125	95	68
Cash & Equivalents	0.00	33	16	28
Short-Term Investments	0.00	55	71	32
Accounts Receivable	21	30	3.84	5.27
Prepaid Expenses	1.41	6.40	4.07	3.43
Plant, Property, & Equipment, net	6.80	20	18	15
Total Noncurrent Assets	275	276	262	242
Goodwill	84	84	84	84
Intangible Assets	176	167	155	138
Other Noncurrent Operating Assets	15	25	23	20
Total Liabilities & Shareholders' Equity	304	421	375	326
Total Liabilities	70	80	61	38
Total Current Liabilities	21	26	23	15
Short-Term Debt	2.54	4.02	1.30	0.53
Accounts Payable	2.92	2.97	4.41	2.30
Accrued Expenses	3.75	5.56	7.07	6.14
Current Deferred Revenue	11	8.21	6.85	2.34
Other Current Liabilities	0.58	1.78	3.49	3.78
Total Noncurrent Liabilities	50	54	38	23
Capital Lease Obligations	13	24	22	19
Noncurrent Deferred Revenue	9.23	4.33	0.86	0.12
Noncurrent Deferred & Payable Income Tax Liabilities	22	21	11	2.31
Other Noncurrent Operating Liabilities	5.12	4.14	3.23	1.04
Commitments & Contingencies	-	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	234	341	315	288
Total Preferred & Common Equity	234	341	315	288
Preferred Stock	0.00	0.00	0.00	0.00
Total Common Equity	234	341	315	288
Common Stock	0.00	330	354	389
Retained Earnings	0.00	11	-39	-101
Accumulated Other Comprehensive Income / (Loss)	0.00	0.01	0.05	0.03

This table presents OmniAb's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024
Total Assets	238	413	405	392	353	337	332
Total Current Assets	0.42	121	116	107	77	67	67
Cash & Equivalents	0.02	23	21	21	19	21	27
Short-Term Investments	-	91	82	75	50	36	32
Accounts Receivable	-	1.82	8.61	6.14	4.05	6.88	3.50
Prepaid Expenses	0.40	5.66	4.18	4.08	3.67	3.20	3.73
Plant, Property, & Equipment, net	0.00	19	19	19	18	17	16
Total Noncurrent Assets	237	273	270	266	258	253	249
Goodwill	-	84	84	84	84	84	84
Intangible Assets	-	164	162	159	152	148	144
Other Noncurrent Operating Assets	237	24	24	24	22	21	21
Total Liabilities & Shareholders' Equity	238	413	405	392	353	337	332
Total Liabilities	14	72	71	67	51	43	40
Total Current Liabilities	10	22	24	25	18	14	14
Short-Term Debt	-	2.47	2.81	1.75	0.89	0.33	0.51
Accounts Payable	6.39	2.49	2.36	2.50	3.56	2.81	2.19
Accrued Expenses	1.53	3.91	4.93	6.52	4.03	4.55	5.45
Current Deferred Revenue	-	6.89	7.27	7.38	5.53	2.91	2.51
Other Current Liabilities	2.35	2.44	3.42	3.45	3.52	3.56	3.75
Total Noncurrent Liabilities	4.03	51	47	42	34	29	25
Capital Lease Obligations	-	23	23	23	21	21	20
Noncurrent Deferred Revenue	-	3.02	3.48	1.95	0.28	0.07	0.04
Noncurrent Deferred & Payable Income Tax Liabilities	-	20	17	14	8.74	6.84	4.13
Other Noncurrent Operating Liabilities	4.03	3.73	3.42	3.56	3.21	1.24	1.16
Total Equity & Noncontrolling Interests	-14	341	334	325	301	294	292
Total Preferred & Common Equity	-14	341	334	325	301	294	292
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	-14	341	334	325	301	294	292
Common Stock	0.00	336	343	350	360	366	380
Retained Earnings	-14	5.15	-9.58	-25	-58	-72	-88
Accumulated Other Comprehensive Income / (Loss)	-	0.01	-0.05	-0.05	-0.02	-0.03	0.05

This table displays calculated financial ratios and metrics derived from OmniAb's official financial filings.

Metric	2021	2022	2023	2024
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-
Revenue Growth	0.00%	70.02%	-42.17%	-22.75%
EBITDA Growth	0.00%	52.63%	-522.73%	1.74%
EBIT Growth	0.00%	22.41%	-160.50%	-7.35%
NOPAT Growth	0.00%	25.17%	-160.50%	-7.32%
Net Income Growth	0.00%	17.41%	-126.65%	-22.55%
EPS Growth	0.00%	21.21%	-96.15%	-19.61%
Operating Cash Flow Growth	0.00%	36.76%	165.43%	-1,789.99%
Free Cash Flow Firm Growth	0.00%	0.00%	61.66%	-161.01%
Invested Capital Growth	0.00%	12.23%	-10.59%	-1.15%
Revenue Q/Q Growth	0.00%	0.00%	-47.19%	29.31%
EBITDA Q/Q Growth	0.00%	0.00%	-136.10%	14.03%
EBIT Q/Q Growth	0.00%	0.00%	-77.25%	6.65%
NOPAT Q/Q Growth	0.00%	0.00%	-77.26%	6.67%
Net Income Q/Q Growth	0.00%	0.00%	-70.17%	1.56%
EPS Q/Q Growth	0.00%	0.00%	-82.14%	1.61%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	-45.73%	11.69%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	12.69%
Invested Capital Q/Q Growth	0.00%	0.00%	-0.56%	-1.92%
Profitability Metrics	-	-	-	-
Gross Margin	100.00%	100.00%	100.00%	100.00%
EBITDA Margin	-52.06%	-14.50%	-156.19%	-198.67%
Operating Margin	-102.48%	-45.11%	-203.19%	-282.30%
EBIT Margin	-98.83%	-45.11%	-203.19%	-282.36%
Profit (Net Income) Margin	-77.82%	-37.80%	-148.16%	-235.05%
Tax Burden Percent	78.72%	85.70%	78.65%	86.87%
Interest Burden Percent	100.02%	97.80%	92.72%	95.83%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-9.97%	-7.03%	-18.28%	-20.90%
ROIC Less NNEP Spread (ROIC-NNEP)	-23.35%	9.38%	-15.02%	-1.74%
Return on Net Nonoperating Assets (RNNOA)	-1.58%	-0.73%	2.85%	0.30%
Return on Equity (ROE)	-11.54%	-7.76%	-15.43%	-20.60%
Cash Return on Invested Capital (CROIC)	0.00%	-18.55%	-7.10%	-19.74%
Operating Return on Assets (OROA)	-11.28%	-7.34%	-17.43%	-21.27%
Return on Assets (ROA)	-8.88%	-6.16%	-12.71%	-17.70%
Return on Common Equity (ROCE)	-11.54%	-7.76%	-15.43%	-20.60%
Return on Equity Simple (ROE_SIMPLE)	-11.54%	-6.54%	-16.09%	-21.57%
Net Operating Profit after Tax (NOPAT)	-25	-19	-49	-52
NOPAT Margin	-71.73%	-31.58%	-142.24%	-197.61%
Net Nonoperating Expense Percent (NNEP)	13.38%	-16.41%	-3.26%	-19.16%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-14.38%	-16.96%
Cost of Revenue to Revenue	0.00%	0.00%	0.00%	0.00%
SG&A Expenses to Revenue	48.77%	42.15%	97.51%	116.48%
R&D to Revenue	112.90%	81.87%	165.45%	208.82%
Operating Expenses to Revenue	202.48%	145.11%	303.19%	382.30%
Earnings before Interest and Taxes (EBIT)	-34	-27	-69	-75
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-18	-8.57	-53	-52
Valuation Ratios	-	-	-	-
Price to Book Value (P/BV)	0.00	0.30	2.28	1.49
Price to Tangible Book Value (P/TBV)	0.00	1.15	9.55	6.53
Price to Revenue (P/Rev)	0.00	1.75	20.99	16.23
Price to Earnings (P/E)	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.15	2.60	1.57
Enterprise Value to Revenue (EV/Rev)	0.00	0.73	19.13	14.73
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	278.48	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-
Debt to Equity	0.07	0.08	0.07	0.07
Long-Term Debt to Equity	0.06	0.07	0.07	0.07
Financial Leverage	0.07	-0.08	-0.19	-0.17
Leverage Ratio	1.30	1.26	1.21	1.16
Compound Leverage Factor	1.30	1.23	1.13	1.12
Debt to Total Capital	6.32%	7.59%	6.92%	6.48%
Short-Term Debt to Total Capital	1.01%	1.09%	0.39%	0.17%
Long-Term Debt to Total Capital	5.31%	6.50%	6.53%	6.30%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	93.68%	92.41%	93.08%	93.52%
Debt to EBITDA	-0.87	-3.27	-0.44	-0.38
Net Debt to EBITDA	-0.87	7.03	1.19	0.75
Long-Term Debt to EBITDA	-0.73	-2.80	-0.41	-0.37
Debt to NOPAT	-0.63	-1.50	-0.48	-0.38
Net Debt to NOPAT	-0.63	3.23	1.31	0.76
Long-Term Debt to NOPAT	-0.53	-1.29	-0.45	-0.37
Altman Z-Score	0.00	1.03	6.66	5.86
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-
Current Ratio	1.10	4.80	4.11	4.52
Quick Ratio	1.03	4.56	3.93	4.29
Cash Flow Metrics	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-49	-19	-49
Operating Cash Flow to CapEx	-139.36%	-20.89%	142.76%	-2,115.41%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	-810.29	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	-1,391.71	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-
Asset Turnover	0.11	0.16	0.09	0.08
Accounts Receivable Turnover	1.64	2.30	2.00	5.79
Inventory Turnover	0.00	0.00	0.00	0.00
Fixed Asset Turnover	5.11	4.41	1.79	1.56
Accounts Payable Turnover	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	222.02	158.86	182.34	63.04
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	222.02	158.86	182.34	63.04
Capital & Investment Metrics	-	-	-	-
Invested Capital	250	281	251	248
Invested Capital Turnover	0.14	0.22	0.13	0.11
Increase / (Decrease) in Invested Capital	0.00	31	-30	-2.88
Enterprise Value (EV)	0.00	43	654	389
Market Capitalization	0.00	104	717	428
Book Value per Share	$8.15	$4.00	$2.71	$2.38
Tangible Book Value per Share	($0.90)	$1.06	$0.65	$0.54
Total Capital	250	369	338	308
Total Debt	16	28	23	20
Total Long-Term Debt	13	24	22	19
Net Debt	16	-60	-64	-40
Capital Expenditures (CapEx)	4.07	17	1.64	1.88
Debt-free, Cash-free Net Working Capital (DFCFNWC)	4.50	15	-14	-5.85
Debt-free Net Working Capital (DFNWC)	4.50	103	73	54
Net Working Capital (NWC)	1.97	99	72	53
Net Nonoperating Expense (NNE)	2.12	3.68	2.03	9.88
Net Nonoperating Obligations (NNO)	16	-61	-64	-40
Total Depreciation and Amortization (D&A)	16	18	16	22
Debt-free, Cash-free Net Working Capital to Revenue	12.96%	24.86%	-40.67%	-22.18%
Debt-free Net Working Capital to Revenue	12.96%	174.26%	213.93%	203.03%
Net Working Capital to Revenue	5.66%	167.46%	210.12%	201.02%
Earnings Adjustments	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	($0.26)	($0.51)	($0.61)
Adjusted Weighted Average Basic Shares Outstanding	0.00	85.32M	99.68M	102.37M
Adjusted Diluted Earnings per Share	$0.00	($0.26)	($0.51)	($0.61)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	85.32M	99.68M	102.37M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	115.58M	117.13M	122.13M
Normalized Net Operating Profit after Tax (NOPAT)	-25	-19	-49	-52
Normalized NOPAT Margin	-71.73%	-31.58%	-142.24%	-197.61%
Pre Tax Income Margin	-98.85%	-44.11%	-188.39%	-270.59%
Debt Service Ratios	-	-	-	-
EBIT to Interest Expense	-4,906.14	0.00	0.00	0.00
NOPAT to Interest Expense	-3,560.90	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	-5,487.57	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	-4,142.33	0.00	0.00	0.00
Payout Ratios	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from OmniAb's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	0.00%	75.82%	-3.51%	-20.74%	-86.36%	-77.53%	9.62%	-23.83%	124.06%
EBITDA Growth	-6,000.99%	0.00%	-19.60%	-91.64%	-56.54%	-224.54%	-302.61%	31.58%	7.12%	50.26%
EBIT Growth	-8,640.23%	0.00%	-2.80%	-54.77%	-36.21%	-334.32%	-166.80%	16.12%	2.63%	25.12%
NOPAT Growth	-8,640.23%	0.00%	-2.80%	-54.74%	-36.26%	-331.77%	-166.80%	16.15%	2.71%	25.12%
Net Income Growth	-7,284.26%	0.00%	2.90%	-43.32%	-24.94%	-306.06%	-210.84%	7.45%	-4.03%	7.01%
EPS Growth	0.00%	0.00%	25.00%	-25.00%	-6.67%	-255.56%	-216.67%	13.33%	0.00%	7.14%
Operating Cash Flow Growth	0.00%	0.00%	137.87%	-160.18%	-46.46%	-27.69%	-161.51%	-21.55%	-6.13%	57.55%
Free Cash Flow Firm Growth	0.00%	0.00%	0.00%	78.92%	-785.77%	0.00%	51.75%	73.44%	66.80%	-155.36%
Invested Capital Growth	-2.42%	0.00%	13.52%	15.78%	13.03%	-10.59%	0.64%	0.58%	0.22%	-1.15%
Revenue Q/Q Growth	-4.01%	411.51%	-52.13%	-58.95%	-21.15%	-11.96%	-21.17%	100.32%	-45.21%	158.96%
EBITDA Q/Q Growth	-28.85%	231.64%	-133.04%	-241.93%	-5.25%	-4.73%	-6.82%	41.90%	-42.88%	43.91%
EBIT Q/Q Growth	-18.65%	160.70%	-193.40%	-130.08%	-4.41%	-4.43%	-6.35%	27.66%	-21.20%	19.68%
NOPAT Q/Q Growth	-18.65%	161.37%	-192.39%	-130.04%	-4.47%	-4.39%	-6.35%	27.70%	-21.21%	19.65%
Net Income Q/Q Growth	-22.58%	154.14%	-189.44%	-141.44%	-6.86%	10.71%	-34.92%	28.11%	-20.12%	20.19%
EPS Q/Q Growth	-25.00%	160.00%	-166.67%	-150.00%	-6.67%	12.50%	-35.71%	31.58%	-23.08%	18.75%
Operating Cash Flow Q/Q Growth	-9.87%	-68.79%	487.62%	-136.20%	38.16%	-47.16%	-86.73%	28.48%	46.00%	41.14%
Free Cash Flow Firm Q/Q Growth	97.88%	100.00%	0.00%	-34.74%	10.82%	134.33%	-216.97%	25.83%	-11.46%	42.75%
Invested Capital Q/Q Growth	0.77%	25.70%	-9.84%	1.38%	-1.62%	-0.56%	1.48%	1.32%	-1.98%	-1.92%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
EBITDA Margin	-150.61%	38.76%	-26.76%	-222.85%	-297.44%	-353.84%	-479.51%	-139.09%	-362.68%	-78.55%
Operating Margin	-215.76%	25.60%	-49.96%	-279.95%	-370.91%	-439.78%	-593.34%	-214.15%	-473.73%	-146.98%
EBIT Margin	-215.76%	25.60%	-49.96%	-280.00%	-370.77%	-439.78%	-593.34%	-214.26%	-473.92%	-146.98%
Profit (Net Income) Margin	-182.29%	19.30%	-36.05%	-212.04%	-287.35%	-291.44%	-498.84%	-179.03%	-392.45%	-120.96%
Tax Burden Percent	84.49%	70.77%	85.57%	81.08%	82.65%	70.17%	87.87%	87.78%	85.81%	85.84%
Interest Burden Percent	100.00%	106.49%	84.34%	93.39%	93.77%	94.45%	95.68%	95.19%	96.51%	95.86%
Effective Tax Rate	0.00%	29.23%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	3.81%	-9.75%	-54.19%	-70.61%	-39.56%	-34.43%	-12.65%	-26.79%	-10.88%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	3.13%	-9.34%	-51.31%	-66.41%	-40.84%	-29.71%	-8.74%	-22.21%	-7.10%
Return on Net Nonoperating Assets (RNNOA)	0.00%	-0.56%	1.46%	7.15%	8.75%	7.74%	6.22%	1.58%	4.00%	1.22%
Return on Equity (ROE)	0.00%	3.26%	-8.29%	-47.05%	-61.87%	-31.83%	-28.21%	-11.07%	-22.79%	-9.67%
Cash Return on Invested Capital (CROIC)	0.00%	-17.54%	0.00%	0.00%	0.00%	-7.10%	-23.66%	-22.45%	-22.33%	-19.74%
Operating Return on Assets (OROA)	0.00%	4.17%	-10.20%	-57.67%	-76.22%	-37.73%	-32.62%	-12.53%	-26.75%	-11.07%
Return on Assets (ROA)	0.00%	3.14%	-7.36%	-43.67%	-59.07%	-25.00%	-27.43%	-10.47%	-22.15%	-9.11%
Return on Common Equity (ROCE)	0.00%	3.26%	-4.83%	-27.05%	-35.08%	-31.82%	-28.21%	-11.07%	-22.79%	-9.67%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	-6.50%	-7.97%	-9.17%	0.00%	-21.06%	-21.21%	-21.60%	0.00%
Net Operating Profit after Tax (NOPAT)	-10	6.40	-5.92	-14	-14	-15	-16	-11	-14	-11
NOPAT Margin	-151.03%	18.12%	-34.97%	-195.96%	-259.64%	-307.84%	-415.34%	-149.90%	-331.61%	-102.89%
Net Nonoperating Expense Percent (NNEP)	-21,763.49%	0.68%	-0.42%	-2.89%	-4.21%	1.27%	-4.72%	-3.91%	-4.58%	-3.79%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-4.39%	-	-	-	-3.61%
Cost of Revenue to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SG&A Expenses to Revenue	80.78%	28.88%	48.44%	125.80%	155.40%	163.19%	219.34%	104.61%	169.68%	68.12%
R&D to Revenue	190.87%	36.55%	81.32%	203.47%	253.19%	306.22%	382.82%	183.02%	319.22%	123.16%
Operating Expenses to Revenue	315.76%	74.40%	149.96%	379.95%	470.91%	539.78%	693.34%	314.15%	573.73%	246.98%
Earnings before Interest and Taxes (EBIT)	-15	9.05	-8.45	-19	-20	-21	-23	-16	-20	-16
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-10	14	-4.53	-15	-16	-17	-18	-11	-15	-8.49
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.30	1.25	1.74	1.86	2.28	2.11	1.50	1.71	1.49
Price to Tangible Book Value (P/TBV)	0.00	1.15	4.60	6.61	7.37	9.55	9.71	7.04	7.86	6.53
Price to Revenue (P/Rev)	0.00	1.75	6.41	8.79	9.32	20.99	30.16	20.31	24.49	16.23
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.15	1.33	1.97	2.10	2.60	2.31	1.57	1.82	1.57
Enterprise Value to Revenue (EV/Rev)	0.00	0.73	5.09	7.63	8.21	19.13	27.94	18.65	22.59	14.73
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	27.10	80.15	122.72	278.48	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.08	0.08	0.08	0.08	0.07	0.07	0.07	0.07	0.07
Long-Term Debt to Equity	0.00	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.07
Financial Leverage	0.00	-0.18	-0.16	-0.14	-0.13	-0.19	-0.21	-0.18	-0.18	-0.17
Leverage Ratio	1.05	1.26	1.15	1.16	1.15	1.21	1.19	1.18	1.17	1.16
Compound Leverage Factor	1.05	1.34	0.97	1.08	1.08	1.15	1.14	1.13	1.13	1.12
Debt to Total Capital	0.00%	7.59%	7.06%	7.20%	7.01%	6.92%	6.89%	6.69%	6.60%	6.48%
Short-Term Debt to Total Capital	0.00%	1.09%	0.67%	0.78%	0.50%	0.39%	0.28%	0.10%	0.16%	0.17%
Long-Term Debt to Total Capital	0.00%	6.50%	6.39%	6.42%	6.51%	6.53%	6.62%	6.59%	6.43%	6.30%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	106.21%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	-6.21%	92.41%	92.94%	92.80%	92.99%	93.08%	93.11%	93.30%	93.40%	93.52%
Debt to EBITDA	0.00	-3.27	-2.78	-1.55	-1.08	-0.44	-0.33	-0.34	-0.34	-0.38
Net Debt to EBITDA	0.00	7.03	9.42	4.62	3.19	1.19	0.70	0.58	0.64	0.75
Long-Term Debt to EBITDA	0.00	-2.80	-2.52	-1.38	-1.01	-0.41	-0.32	-0.33	-0.33	-0.37
Debt to NOPAT	0.00	-1.50	-1.38	-1.10	-0.89	-0.48	-0.38	-0.38	-0.37	-0.38
Net Debt to NOPAT	0.00	3.23	4.66	3.27	2.63	1.31	0.80	0.64	0.69	0.76
Long-Term Debt to NOPAT	0.00	-1.29	-1.24	-0.98	-0.83	-0.45	-0.37	-0.37	-0.36	-0.37
Altman Z-Score	0.00	1.31	3.93	5.13	5.54	7.08	7.26	5.94	7.21	6.45
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	41.79%	42.50%	43.29%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.04	4.80	5.59	4.78	4.26	4.11	4.38	4.76	4.63	4.52
Quick Ratio	0.00	4.56	5.32	4.61	4.10	3.93	4.17	4.53	4.37	4.29
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-4.89	0.00	-36	-49	-43	15	-17	-13	-14	-8.23
Operating Cash Flow to CapEx	-108.10%	-142.40%	11,832.48%	-1,232.72%	-1,264.90%	-8,524.30%	-1,839.31%	-1,622.10%	-4,327.63%	-8,417.39%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.16	0.20	0.21	0.21	0.09	0.06	0.06	0.06	0.08
Accounts Receivable Turnover	0.00	2.30	0.00	0.00	0.00	2.00	7.18	2.80	4.24	5.79
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	4.41	0.00	0.00	0.00	1.79	1.13	1.19	1.17	1.56
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	158.86	0.00	0.00	0.00	182.34	50.85	130.16	86.13	63.04
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	0.00	158.86	0.00	0.00	0.00	182.34	50.85	130.16	86.13	63.04
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	223	281	253	257	252	251	255	258	253	248
Invested Capital Turnover	0.00	0.21	0.28	0.28	0.27	0.13	0.08	0.08	0.08	0.11
Increase / (Decrease) in Invested Capital	-5.55	0.00	30	35	29	-30	1.61	1.49	0.55	-2.88
Enterprise Value (EV)	0.00	43	338	504	531	654	588	405	461	389
Market Capitalization	0.00	104	425	581	603	717	635	441	500	428
Book Value per Share	($0.48)	$4.00	$2.95	$2.89	$2.79	$2.71	$2.57	$2.50	$2.47	$2.38
Tangible Book Value per Share	($0.48)	$1.06	$0.80	$0.76	$0.70	$0.65	$0.56	$0.53	$0.54	$0.54
Total Capital	223	369	367	360	349	338	324	315	312	308
Total Debt	0.00	28	26	26	24	23	22	21	21	20
Total Long-Term Debt	0.00	24	23	23	23	22	21	21	20	19
Net Debt	-0.02	-60	-88	-77	-72	-64	-47	-36	-39	-40
Capital Expenditures (CapEx)	3.92	5.02	0.23	0.81	0.49	0.11	0.93	0.75	0.15	0.05
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-9.86	15	-12	-8.64	-13	-14	-8.92	-3.75	-6.66	-5.85
Debt-free Net Working Capital (DFNWC)	-9.84	103	102	95	84	73	60	53	53	54
Net Working Capital (NWC)	-9.84	99	99	92	82	72	59	53	52	53
Net Nonoperating Expense (NNE)	2.16	-0.42	0.18	1.12	1.52	-0.79	3.17	2.22	2.54	1.95
Net Nonoperating Obligations (NNO)	-0.02	-61	-88	-77	-72	-64	-47	-36	-39	-40
Total Depreciation and Amortization (D&A)	4.50	4.65	3.93	3.97	4.02	4.14	4.33	5.72	4.64	7.39
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	24.86%	-17.67%	-13.07%	-20.23%	-40.67%	-42.38%	-17.27%	-32.65%	-22.18%
Debt-free Net Working Capital to Revenue	0.00%	174.26%	153.49%	142.94%	129.15%	213.93%	285.51%	246.27%	258.30%	203.03%
Net Working Capital to Revenue	0.00%	167.46%	149.77%	138.69%	126.44%	210.12%	281.27%	244.76%	255.80%	201.02%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.18)	$0.09	($0.06)	($0.15)	($0.16)	($0.14)	($0.19)	($0.13)	($0.16)	($0.13)
Adjusted Weighted Average Basic Shares Outstanding	28.75M	85.32M	99.16M	99.49M	99.91M	99.68M	100.76M	101.46M	102.39M	102.37M
Adjusted Diluted Earnings per Share	($0.18)	$0.09	($0.06)	($0.15)	($0.16)	($0.14)	($0.19)	($0.13)	($0.16)	($0.13)
Adjusted Weighted Average Diluted Shares Outstanding	28.75M	85.32M	99.16M	99.49M	99.91M	99.68M	100.76M	101.46M	102.39M	102.37M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	115.58M	115.60M	116.17M	116.24M	117.13M	117.62M	118.16M	121.01M	122.13M
Normalized Net Operating Profit after Tax (NOPAT)	-10	6.40	-5.92	-14	-14	-15	-16	-11	-14	-11
Normalized NOPAT Margin	-151.03%	18.12%	-34.97%	-195.96%	-259.64%	-307.84%	-415.34%	-149.90%	-331.61%	-102.89%
Pre Tax Income Margin	-215.76%	27.27%	-42.14%	-261.50%	-347.67%	-415.35%	-567.69%	-203.95%	-457.36%	-140.90%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials Breakdown Chart

Key Financial Trends

OmniAb (NASDAQ: OABI) has been experiencing a challenging financial period over the past four years, with persistent net losses and significant operating expenses outweighing its revenues. Below is a detailed analysis based on the quarterly financial statements from Q3 2022 through Q4 2024.

Positive Financial Trends

Operating Revenue showed a significant increase in Q4 2024, reaching $10.8 million, the highest quarterly revenue recorded in the past two years.
The company consistently generated positive gross profit each quarter, indicating its core operations can produce profit before overhead costs.
Impairment or other operating income adjustments have slightly improved operating expense profiles in some quarters (e.g., negative other operating expenses/income).
OmniAb has maintained a strong cash and investment position, with cash, short-term investments, and liquid asset sales helping support liquidity across quarters.
The company raised capital through common equity issuances frequently, notably $9.7 million in Q4 2022 and consistent equity issuances in 2023 and 2024, supporting its cash flows.
Depreciation and amortization expenses, while increased, reflect investments in assets and intangible assets that might contribute to long-term value.

Neutral or Mixed Financial Indicators

Total operating expenses remain extremely high, heavily driven by research and development (R&D) and selling, general & administrative (SG&A) expenses, consistent with industry expectations for biotech firms in development stage.
OmniAb’s weighted average shares outstanding increased slightly over time, diluting per-share losses moderately but providing necessary capital.
The company’s capital lease obligations and deferred revenue liabilities remain steady, suggesting contractual and revenue recognition consistency.
Seasonal fluctuations are visible in revenues and cash flow from operations, typical in biotech development depending on milestones and collaborations.

Negative Financial Trends and Risks

OmniAb has incurred consecutive quarterly net losses throughout the past four years, with Q4 2024 reporting a net loss of $13.1 million, and no quarter displaying net profitability recently.
Operating expenses greatly exceed revenues; for instance, in Q4 2024, total operating expenses were $26.7 million against revenue of $10.8 million, reflecting unsustainable burn without profitability.
Cash flow from continuing operating activities has been negative continuously, with Q4 2024 showing a cash burn of approximately $3.9 million, raising concerns about ongoing funding needs.
Declining cash and equivalents from over $90 million in short-term investments in early 2023 to lower levels by late 2024 could pressure financial flexibility if new capital is not raised.
Amortization expenses remain high, partly related to intangible assets, which may signal significant acquisition or license costs without immediate revenue contributions.
EPS (Earnings Per Share) remains negative each quarter, with the most recent Q4 2024 EPS at -$0.13 diluted, reflecting continued losses and no near-term earnings improvement indicated.
The company's total liabilities are significant, with total liabilities around $71M in early 2023, although management of liabilities appears stable in recent quarters.
Negative operating income has not improved significantly in recent quarters, signaling ongoing challenges in scaling revenue or controlling costs effectively.

Summary

OmniAb is in an extended phase of investment with high R&D and operating costs leading to persistent net losses and negative operating cash flow. Although revenue has shown modest growth, expenses outpace income substantially. The company relies heavily on equity financing to sustain operations, and its liquidity and capital resources must be managed carefully to avoid financial distress. Retail investors should be aware that OmniAb remains in a developmental stage with high operating risk and no recent profitability, but its improved revenue trends and strong capital structure provide some buffer for future opportunities.

10/10/25 03:32 PM ETAI Generated. May Contain Errors.

Frequently Asked Questions About OmniAb's Financials

When does OmniAb's fiscal year end?

According to the most recent income statement we have on file, OmniAb's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has OmniAb's net income changed over the last 3 years?

OmniAb's net income appears to be on an upward trend, with a most recent value of -$62.03 million in 2024, rising from -$27.04 million in 2021. The previous period was -$50.62 million in 2023. Check out OmniAb's forecast to explore projected trends and price targets.

What is OmniAb's operating income?

OmniAb's total operating income in 2024 was -$74.50 million, based on the following breakdown:

Total Gross Profit: $26.39 million
Total Operating Expenses: $100.89 million

How has OmniAb's revenue changed over the last 3 years?

Over the last 3 years, OmniAb's total revenue changed from $34.75 million in 2021 to $26.39 million in 2024, a change of -24.1%.

How much debt does OmniAb have?

OmniAb's total liabilities were at $37.94 million at the end of 2024, a 37.4% decrease from 2023, and a 45.9% decrease since 2021.

How much cash does OmniAb have?

In the past 3 years, OmniAb's cash and equivalents has ranged from $0.00 in 2021 to $33.39 million in 2022, and is currently $27.60 million as of their latest financial filing in 2024.

How has OmniAb's book value per share changed over the last 3 years?

Over the last 3 years, OmniAb's book value per share changed from 8.15 in 2021 to 2.38 in 2024, a change of -70.8%.

Related Companies

This page (NASDAQ:OABI) was last updated on 10/10/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

OmniAb (OABI) Financials

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About OmniAb's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

OmniAb (OABI) Financials

Annual Income Statements for OmniAb

Quarterly Income Statements for OmniAb

Annual Cash Flow Statements for OmniAb

Quarterly Cash Flow Statements for OmniAb

Annual Balance Sheets for OmniAb

Quarterly Balance Sheets for OmniAb

Annual Metrics And Ratios for OmniAb

Quarterly Metrics And Ratios for OmniAb

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About OmniAb's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools